Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Factor Support Network (FSN) is a specialty pharmacy dedicated to providing comprehensive care and medication management for individuals with hemophilia, von Willebrand disease, and other bleeding disorders. Headquartered in Camarillo, California, the company specializes in the distribution of clotting factor replacements and offers personalized clinical support, insurance navigation, and patient education. FSN is recognized for its "Factor Support Network Approach," which emphasizes patient-centric service and advocacy to improve health outcomes. The company operates as a key brand within the BioMatrix Specialty Infusion Pharmacy network, providing nationwide access to specialized therapies. BioMatrix, including the FSN brand, was acquired by Frazier Healthcare Partners in 2024 to further expand its home-based infusion and specialty pharmacy services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Factor Support Network.